MPW — Medical Properties Trust Income Statement
0.000.00%
Last trade - 00:00
- $2.66bn
- $12.48bn
- $871.80m
- 45
- 79
- 31
- 50
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 854 | 1,249 | 1,545 | 1,543 | 872 |
Cost of Revenue | |||||
Gross Profit | 836 | 1,230 | 1,512 | 1,503 | 836 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 294 | 440 | 506 | 808 | 1,167 |
Operating Profit | 560 | 809 | 1,039 | 735 | -296 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 374 | 463 | 731 | 960 | -687 |
Provision for Income Taxes | |||||
Net Income After Taxes | 376 | 432 | 657 | 904 | -556 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 375 | 431 | 656 | 903 | -556 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 372 | 429 | 654 | 901 | -558 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.838 | 0.848 | 1.03 | 1.08 | -0.521 |
Dividends per Share |